Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02642016
Title A Study to Evaluate the Safety and Pharmacokinetics of KTN0158 in Adult Patients With Advanced Solid Tumors
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Kolltan Pharmaceuticals, Inc.
Indications

Advanced Solid Tumor

Therapies

CDX-0158

Age Groups: adult
Covered Countries USA

Additional content available in CKB BOOST